XVIVO is listed on Nasdaq Stockholm mid cap list.
XVIVO is listed on Nasdaq Stockholm mid cap list. The share has been listed on Nasdaq Stockholm mid cap since November 28, 2016. The XVIVO share was before that listed on Nasdaq First North since October 8, 2012.
ISIN-code: SE0004840718
Ticker: XVIVO
Trading lot: 1 share
| X-Date | Dividend | Adjusted Dividend | Type |
|---|---|---|---|
| 2023-04-26 | – | – | Ordinary |
| 2022-04-27 | – | – | Ordinary |
| 2021-04-23 | – | – | Ordinary |
| 2020-04-01 | – | – | Ordinary |
| 2019-04-26 | – | – | Ordinary |
| 2018-04-30 | – | – | Ordinary |
| 2017-04-27 | – | – | Ordinary |
| 2016-05-04 | – | – | Ordinary |
| 2015-04-24 | – | – | Ordinary |
| 2014-04-30 | – | – | Ordinary |
| 2013-05-08 | – | – | Ordinary |
In connection with XVIVO´s acquisition of Vivoline Medical AB the Swedish Tax Agency decided the tax treatment for the Vivoline shares purchased by XVIVO AB.
Further information can be found on the Swedish Tax Agency’s website www.skatteverket.se or by using the links below:
Skatteverkets Brevsvar ang. XVIVOs köp av Aktier och Optioner i Vivoline
In connection with Vitrolife’s distribution of the shares in XVIVO AB, the Swedish Tax Agency has decided that 77% of the acquisition cost should be allotted to Vitrolife AB and 23% to XVIVO AB.
Further information can be found on the Swedish Tax Agency’s website www.skatteverket.se or by using the links below:
Skatteverkets allmänna rad (SKV A 2012-28)
Skatteverkets meddelande (SKV M 2012-25)